65 results
8-K
EX-99.1
ZLAB
Zai Lab Limited
8 May 24
Zai Lab Announces First Quarter 2024
4:09pm
interim long-term data from the Phase 3 EMERGENT program at the Annual Congress of the Schizophrenia International Research Society (SIRS).
◦In the new … interim analysis of long-term efficacy data from the Phase 3 EMERGENT-4 open-label extension trial, KarXT was associated with significant improvement
8-K
EX-99.1
9ta4wa4da
27 Feb 24
Zai Lab Announces Full-Year 2023
4:12pm
8-K
EX-99.1
ousm px0n
7 Nov 23
Zai Lab Announces Third Quarter 2023
4:10pm
8-K
EX-99.1
rm7mf0c2ko98gqw3mp
7 Aug 23
Zai Lab Announces Second Quarter 2023
4:07pm
8-K
EX-99.1
n6068mva53998
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm
8-K
EX-99.1
kzio33gn13bkekk
9 Nov 22
Zai Lab Announces Third Quarter 2022
4:13pm
8-K
i25gn79hw7s 4zn
28 Oct 22
Departure of Directors or Certain Officers
4:56pm
8-K
EX-99.1
xz1beh pg2e2c9
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
EX-99.1
ncm1x8n
31 May 22
Other Events
8:51am